Psychiatrist Dr. Matt Bernstein, CEO of the metabolic psychiatry program Accord, discusses how brain energy metabolism — not just neurotransmitters — may underlie depression, bipolar disorder, schizophrenia, and even Alzheimer’s risk decades before symptoms appear. He explains how ketogenic and low-carbohydrate approaches can reduce food noise and cravings for people in food addiction recovery, and compares these dietary interventions to GLP-1 medications. The episode also covers the risks of rapid, unsupported psychiatric medication tapering.
Footer
Follow Us!
